Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,424
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Jacksonville FL, Fairhope AL, Daphne AL,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Location: Tampa FL, Orlando FL, Miami FL, Atlanta GA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 18+
Code: NCT06765109
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
for
Solid Tumor
Location: Tampa FL, Augusta GA, Chicago IL, New York NY,
Sponsor: Eisai Inc.
Sex: All
Age: 18+
Code: NCT04300556
Phase 1, Phase 2, Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: Tampa FL, Jacksonville FL, Spartanburg SC, Durham NC,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase 1, Phase 2, Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for
Adult Acute Myeloid Leukemia
Location: Tampa FL, Atlanta GA, Cincinnati OH, Cleveland OH,
Sponsor: Priothera SAS
Sex: All
Age: 18 - 70+
Code: NCT05429632
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Gainesville FL, Savannah GA, Bluffton SC,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer (Adenocarcinoma),
Location: Tampa FL, Myrtle Beach SC, Baltimore MD, Boston MA,
Sponsor: Acerand Therapeutics (Hong Kong) Limited
Sex: Male
Age: 18+
Code: NCT06801236
Phase 1, Recruiting
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
for
NSCLC Stage IV
Location: Tampa FL, Fort Myers FL, Fort Lauderdale FL, Miami FL,
Sponsor: ImmunityBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06745908
Phase 3, Recruiting
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
for
Severe Aplastic Anemia
Location: Tampa FL, Atlanta GA, Birmingham AL, Charlotte NC,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 3 - 70+
Code: NCT06517641
Phase 2, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Tampa FL, Jacksonville FL, Miami FL, Atlanta GA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Pembroke Pines FL, Hollywood FL, Savannah GA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase 2, Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
for
Endometrial Cancer
Location: Tampa FL, Orlando FL, Augusta GA, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: Female
Age: 18 - 70
Code: NCT06481592
Phase 2, Recruiting
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
for
Ovarian Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: Female
Age: 18+
Code: NCT05316129
Phase 1, Recruiting
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
for
Ovarian Cancer, Cholangiocarcinoma Recurrent,
Location: Tampa FL, Houston TX, Philadelphia PA, Madison WI
Sponsor: Verismo Therapeutics
Sex: All
Age: 18+
Code: NCT05568680
Phase 1, Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: Tampa FL, Bradenton FL, Sarasota FL, N. Venice FL,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase 2, Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Tampa FL, Atlanta GA, Louisville KY, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03761108
Phase 1, Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Tampa FL, Orange City FL, Palm Bay FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
for
Pancreatic Carcinoma, Pancreatic Neoplasm
Location: Tampa FL, Lexington KY, Richmond VA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06807437
Phase 3, Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for
Breast Cancer
Location: Tampa FL, Jacksonville FL, Tallahassee FL, Weston FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06790693
Phase 3, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Jacksonville FL, Charlottesville VA,